These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17245808)

  • 1. Proteomic biomarker identification for diagnosis of early relapse in ovarian cancer.
    Oh JH; Nandi A; Gurnani P; Knowles L; Schorge J; Rosenblatt KP; Gao JX
    J Bioinform Comput Biol; 2006 Dec; 4(6):1159-79. PubMed ID: 17245808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of early relapse in ovarian cancer using serum proteomic profiling.
    Oh JH; Gao J; Nandi A; Gurnani P; Knowles L; Schorge J
    Genome Inform; 2005; 16(2):195-204. PubMed ID: 16901102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of two-stage SVM-RFE gene selection strategy for microarray expression data analysis.
    Tang Y; Zhang YQ; Huang Z
    IEEE/ACM Trans Comput Biol Bioinform; 2007; 4(3):365-81. PubMed ID: 17666757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple SVM-RFE for gene selection in cancer classification with expression data.
    Duan KB; Rajapakse JC; Wang H; Azuaje F
    IEEE Trans Nanobioscience; 2005 Sep; 4(3):228-34. PubMed ID: 16220686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feature selection and nearest centroid classification for protein mass spectrometry.
    Levner I
    BMC Bioinformatics; 2005 Mar; 6():68. PubMed ID: 15788095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recursive gene selection based on maximum margin criterion: a comparison with SVM-RFE.
    Niijima S; Kuhara S
    BMC Bioinformatics; 2006 Dec; 7():543. PubMed ID: 17187691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian cancer identification based on dimensionality reduction for high-throughput mass spectrometry data.
    Yu JS; Ongarello S; Fiedler R; Chen XW; Toffolo G; Cobelli C; Trajanoski Z
    Bioinformatics; 2005 May; 21(10):2200-9. PubMed ID: 15784749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recursive SVM feature selection and sample classification for mass-spectrometry and microarray data.
    Zhang X; Lu X; Shi Q; Xu XQ; Leung HC; Harris LN; Iglehart JD; Miron A; Liu JS; Wong WH
    BMC Bioinformatics; 2006 Apr; 7():197. PubMed ID: 16606446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the GA/KNN method to SELDI proteomics data.
    Li L; Umbach DM; Terry P; Taylor JA
    Bioinformatics; 2004 Jul; 20(10):1638-40. PubMed ID: 14962943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guilt-by-association feature selection: identifying biomarkers from proteomic profiles.
    Shin H; Sheu B; Joseph M; Markey MK
    J Biomed Inform; 2008 Feb; 41(1):124-36. PubMed ID: 17544868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An extended Markov blanket approach to proteomic biomarker detection from high-resolution mass spectrometry data.
    Oh JH; Gurnani P; Schorge J; Rosenblatt KP; Gao JX
    IEEE Trans Inf Technol Biomed; 2009 Mar; 13(2):195-206. PubMed ID: 19126475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data.
    Wu B; Abbott T; Fishman D; McMurray W; Mor G; Stone K; Ward D; Williams K; Zhao H
    Bioinformatics; 2003 Sep; 19(13):1636-43. PubMed ID: 12967959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new approach for the analysis of mass spectrometry data for biomarker discovery.
    Barbarini N; Magni P; Bellazzi R
    AMIA Annu Symp Proc; 2006; 2006():26-30. PubMed ID: 17238296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic studies of early-stage and advanced ovarian cancer patients.
    Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
    Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feature extraction and quantification for mass spectrometry in biomedical applications using the mean spectrum.
    Morris JS; Coombes KR; Koomen J; Baggerly KA; Kobayashi R
    Bioinformatics; 2005 May; 21(9):1764-75. PubMed ID: 15673564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of mass spectral serum profiles for biomarker selection.
    Ressom HW; Varghese RS; Abdel-Hamid M; Eissa SA; Saha D; Goldman L; Petricoin EF; Conrads TP; Veenstra TD; Loffredo CA; Goldman R
    Bioinformatics; 2005 Nov; 21(21):4039-45. PubMed ID: 16159919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach for clustering proteomics data using Bayesian fast Fourier transform.
    Bensmail H; Golek J; Moody MM; Semmes JO; Haoudi A
    Bioinformatics; 2005 May; 21(10):2210-24. PubMed ID: 15769836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MSVM-RFE: extensions of SVM-RFE for multiclass gene selection on DNA microarray data.
    Zhou X; Tuck DP
    Bioinformatics; 2007 May; 23(9):1106-14. PubMed ID: 17494773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma proteomic pattern as biomarkers for ovarian cancer.
    Lin YW; Lin CY; Lai HC; Chiou JY; Chang CC; Yu MH; Chu TY
    Int J Gynecol Cancer; 2006; 16 Suppl 1():139-46. PubMed ID: 16515582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.